Molecule Structure

Scientific Name

Tadalafil

Description of the Drug

Tadalafil is a phosphodiesterase 5 inhibitor used to treat erectile dysfunction, benign prostatic hyperplasia, and pulmonary arterial hypertension.

Source: DrugBank Online – DrugBank.com. Retrieved 2023-03-10 from
http://www.drugbank.ca/drugs/DB00820

Brand Name(s)

Adcirca, Cialis, Tadliq

Company Owner(s)

Sunshine Lake Pharma Co Ltd, Cmp Development Llc, Cipla Ltd, Macleods Pharmaceuticals Ltd, Watson Laboratories Inc, Eli Lilly Co, Zydus Pharmaceuticals Usa Inc, Prinston Pharmaceutical Inc, Torrent Pharmaceuticals Ltd, Teva Pharmaceuticals Usa Inc

Mechanism(s) Of Action

Target Name Target Type Action Type Target ChEMBL ID
Phosphodiesterase 5A SINGLE PROTEIN INHIBITOR CHEMBL1827

Unichem Links

SureChEMBL SCHEMBL33333
PharmGKB PA10333
Human Metabolome Database HMDB0014958
DrugBank DB00820
PubChem: Thomson Pharma 14756405 14805118
PubChem 110635
LINCS LSM-4109
Nikkaji J1.662.659G
PDBe CIA
BindingDB 14777
EPA CompTox Dashboard DTXSID9046786
DrugCentral 2553
Brenda 1339
ChemicalBook CB2236841
Guide to Pharmacology 7299
rxnorm TADALAFIL ADCIRCA CIALIS
PubChem: Drugs of the Future 12015128
ChEBI 71940
ZINC ZINC000003993855